Karl Andersen is an Executive Business Director in Cardiometabolic Health at Eli Lilly and Company, having transitioned into this role in 2025 after serving as a Senior District Sales Manager overseeing a territory from the Bronx to Binghamton. With 15 years of experience in the diabetes sector, they began their career as a Sales Representative at Eli Lilly from 2003 to 2011 before taking on various managerial roles within the company. Andersen holds a Bachelor’s degree in Speech Communication and Rhetoric from Iona College, earned in 1997.
This person is not in any teams
This person is not in any offices